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Role of Adiponectin and Inflammation in
Insulin Resistance of Mc3r and Mc4r Knockout
Mice
James L. Trevaskis,* Barbara Gawronska-Kozak,* Gregory M. Sutton,* Michele McNeil,*
Jacqueline M. Stephens,† Steven R. Smith,* and Andrew A. Butler*
Abstract
TREVASKIS, JAMES L., BARBARA GAWRONSKA-
KOZAK, GREGORY M. SUTTON, MICHELE MCNEIL,
JACQUELINE M. STEPHENS, STEVEN R. SMITH,
AND ANDREW A. BUTLER. Role of adiponectin and
inflammation in insulin resistance of Mc3r and Mc4r
knockout mice. Obesity. 2007;15:2664–2672.
Objective: To investigate the involvement of hypoadi-
ponectinemia and inflammation in coupling obesity to in-
sulin resistance in melanocortin-3 receptor and melanocor-
tin-4 receptor knockout (KO) mice (Mc3/4rKO).
Research Methods and Procedures: Sera and tissue were
collected from 6-month-old Mc3rKO, Mc4rKO, and wild-
type C57BL6J litter mates maintained on low-fat diet or
exposed to high-fat diet (HFD) for 1 or 3 months. Inflam-
mation was assessed by both real-time polymerase chain
reaction analysis of macrophage-specific gene expression
and immunohistochemistry.
Results: Mc4rKO exhibited hypoadiponectinemia, exacer-
bated by HFD and obesity, previously reported in murine
models of obesity. Mc4r deficiency was also associated with
high levels of macrophage infiltration of adipose tissue,
again exacerbated by HFD. In contrast, Mc3rKO exhibited
normal serum adiponectin levels, irrespective of diet or
obesity, and a delayed inflammatory response to HFD rel-
ative to Mc4rKO.
Discussion: Our findings suggest that severe insulin resis-
tance of Mc4rKO fed a HFD, as reported in other models of
obesity such as leptin-deficient (Lepob/Lepob) and KK-Ay
mice, is linked to reduced serum adiponectin and high levels
of inflammation in adipose tissue. Conversely, maintenance
of normal serum adiponectin may be a factor in the rela-
tively mild insulin-resistant phenotype of severely obese
Mc3rKO. Mc3rKO are, thus, a unique mouse model where
obesity is not associated with reduced serum adiponectin
levels. A delay in macrophage infiltration of adipose tissue
of Mc3rKO during exposure to HFD may also be a factor
contributing to the mild insulin resistance in this model.
Key words: hypothalamic neurotransmitters, macro-
phages, dietary fat, inflammation, insulin resistance
Introduction
An increasing occurrence of obesity has been associated
with a parallel rise in the incidence of metabolic syndrome,
a cluster of diseases with insulin resistance as the defining
feature (1). The pathogenesis of obesity-related insulin re-
sistance is poorly understood. Several mechanisms have
been proposed to explain the increased risk of insulin resis-
tance, including an imbalance of fat intake and oxidation
associated with defects in oxidative metabolism (2), hypo-
thalamic dysfunction (3), and oxidative stress and inflam-
mation in adipocytes (4). It is likely that no single mecha-
nism will explain obesity-related insulin resistance and that
insulin resistance and type 2 diabetes represent the culmi-
nation of a cascade of events.
The axes involving factors secreted from the gut and
adipose tissue that act on melanocortin neurons in the cen-
tral nervous system have been the most intensively inves-
tigated homeostatic system involved in energy homeostasis
and insulin resistance (3,5). Leptin deficiency is associated
with insulin resistance and steatosis (6–9). Intracerebroven-
tricular administration of leptin improves hepatic insulin
sensitivity, independently of effects on food intake (10).
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Administration of non-selective melanocortin agonists in-
tracerebroventricularly also improves insulin sensitivity in-
dependently of reduced food intake (11). The selective roles
of two melanocortin receptors expressed in the central ner-
vous system (Mc3r, Mc4r) in energy homeostasis and insu-
lin resistance have been investigated using knockout (KO)1
mice (Mc3rKO, Mc4rKO). The initial analysis of obesity
and diabetes (diabesity) in melanocortin receptor KO mice
suggested a role for the Mc4r in the regulation of insulin
action (12,13). Analysis of the phenotype of melanocortin
receptor KO mice backcrossed onto the C57BL/6J (B6)
background also suggests that insulin resistance is most
severe for Mc4rKO (14). The mechanisms explaining the
differential effects of melanocortin receptor genotype on
insulin resistance in the obese state are unclear.
Altered metabolic state of adipose tissue has also been
linked to the development of obesity and insulin resistance.
Serum levels of the adipocyte-derived hormone adiponectin
are reduced in states of obesity and diabetes (15). Admin-
istration of adiponectin protein inhibits endogenous glucose
production in the liver and improves obesity-associated
insulin resistance (16,17). Macrophage infiltration of adi-
pose tissue has also been observed in obesity-related insulin
resistance (18,19), possibly mediated by increased levels of
the chemokine monocyte chemoattractant protein (MCP)-1
(20).
The objective of these studies was to investigate adipo-
cytokine production and adipose tissue inflammation in
Mc3rKO and Mc4rKO. We also measured adipocyte size
because human obesity and insulin resistance are associated
with an increase in both the number and size of adipocytes
(21). Our data suggest that differences in the effects of
obesity on serum adiponectin and the severity of inflamma-
tion may contribute to the observed differences in hyperin-
sulinemia in severely obese Mc3rKO and Mc4rKO.
Research Methods and Procedures
Experimental Animals
The Pennington Biomedical Research Center Institutional
Animal Care and Use Committee approved all experiments.
Mc3rKO, Mc4rKO, and wild-type mice (WT) B6 litter-
mates were obtained from mating heterozygote parents, as
described previously (22,23). Mice were housed on a 12-
hour light/dark period (lights on, 6 AM to 6 PM) and fed
standard chow from weaning to 12 to 14 weeks of age.
Mice were then fed either purified low-fat diet (LFD; Re-
search Diets 12450B, Research Diets, New Brunswick, NJ;
10% kJ/fat; 10 to 12 of each genotype) or high-fat diet
(HFD; Research Diets 12492, 60% kJ/fat; five to six of each
genotype) for 3 months. Mice were sacrificed at 24 to 26
weeks of age. Four weeks before sacrifice, half of the LFD
group were fed HFD ad libitum. Adiposity (percentage
body fat) was estimated by measuring fat mass and fat-free
mass by nuclear magnetic resonance (Bruker Mice Minis-
pec NMR Analyzer; Bruker Optics Inc., Billerica, MA),
validated against DXA and standard chemical composition
analysis (24).
Gene Expression
Total RNA from retroperitoneal adipose tissue was iso-
lated using TRI Reagent (Molecular Research Centre Inc.,
Cincinnati, OH), quantitated by the Agilent 2100 Bioana-
lyzer (Agilent Technologies, Palo Alto, CA) and reverse
transcribed using the Superscript III reverse transcription
system (Invitrogen, Carlsbad, CA). Oligonucleotide primers
(Integrated DNA Technologies, Coralville, IA) were de-
signed using Primer Express 2.0 software (Applied Biosys-
tems, Foster City, CA). Quantitation of target gene mRNA
using cyclophilin B as a reference was performed in 384-
well plates using SYBR Green or Taqman Universal PCR
Master Mix (Applied Biosystems) and an ABI PRISM 7900
HT Sequence Detection System (Applied Biosystems). Se-
quences of primers and probes used for expression analyses
were: cyclophilin B, sense, 5-ggtggagagcaccaagacaga-3,
antisense, 5-gccggagtcgacaatgatg-3; probe, 5-agccggga-
caagccactgaaggat-3; adiponectin (Acrp30; adipocyte
complement-related protein of 30 kDa), sense, 5-gctcct-
gctttggtccctccac-3, antisense, 5-gcccttcagctcctgtcattcc-3;
epidermal growth factor-like module-containing, mucin-
like, hormone receptor-like sequence (Emr1; epidermal
growth factor-like module containing, mucin-like, hormone
receptor-like 1), sense 5-ctttggctatgggcttccagtc-3, anti-
sense, 5-gcaaggaggacagagtttatcgtg-3; CD68 antigen
(Cd68) sense, 5-cttcccacaggcagcacag-3, antisense, 5-aat-
gatgagaggcagcaagag-3; and Mcp1, sense, 5-ttggctcagcca-
gatgca-3, antisense, 5-ccagcctactcattgggatca-3. The
5-carboxyfluorescein-labeled probe was synthesized by Ap-
plied Biosystems.
Serum Assays
Total serum insulin and leptin (Crystal Chem, Downer’s
Grove, IL) and adiponectin (Linco Research, St. Charles,
MO) were measured by enzyme-linked immunosorbent as-
say performed in duplicate.
Gel Electrophoresis and Immunoblotting
Serum adiponectin immunoreactivity was examined un-
der non-denaturing conditions to investigate the effect of
obesity on the low-molecular weight, middle-molecular
weight (MMW), and high-molecular weight (HMW) mul-
timers (25). Proteins were separated in 7.5% polyacryl-
1 Nonstandard abbreviations: KO, knockout; Mc3rKO, Mc3r KO mice; Mc4rKO, Mc4r KO
mice; MCP, monocyte chemoattractant protein; WT, wild type mice; LFD, low-fat diet;
HFD, high-fat diet; Acrp30, adipocyte complement-related protein of 30 kDa; Emr1,
epidermal growth factor-like module containing, mucin-like, hormone receptor-like 1;
MMW, middle molecular weight; HMW, high molecular weight; WAT, white adipose
tissue; MW, molecular weight.
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amide gels that either contained sodium dodecyl sulfate or
were devoid of sodium dodecyl sulfate. The gels were
transferred to nitrocellulose (Bio-Rad, Hercules, CA) in 25
mM Tris, 192 mM glycine, and 20% methanol. After trans-
fer, the membrane was blocked in 4% milk for 1 hour at
room temperature. Results were visualized with horseradish
peroxidase-conjugated secondary antibodies (Sigma, St.
Louis, MO) and enhanced chemiluminescence (Pierce,
Rockford, IL). An adiponectin polyclonal antibody was
purchased from Affinity Bioreagents (Golden, CO) and
used at a dilution of 4 g/mL.
Fat Cell Size Analysis
Fat cell size was determined as previously described (26).
Briefly, adipose tissue was fixed in osmium tetrachloride/
collidine-HCl after disassociation by urea digestion. Cells
were counted on a Multisizer-3 (Beckman Coulter, Fuller-
ton, CA) using a 400-m aperture (dynamic linear range, 12
to 320 m).
Immunohistochemistry
Formalin-fixed fat depot samples were processed, em-
bedded in paraffin, and sectioned at 5 m. Dewaxed sec-
tions were treated with 3% H2O2 in methanol (Sigma) for 30
minutes to block endogenous peroxidases followed by nor-
mal horse serum to reduce non-specific staining. Consecu-
tive sections were incubated overnight (4 °C) with the fol-
lowing monoclonal primary antibodies: anti-mouse Mac-2
(1:3000; Cedarlane Laboratories, Ontario, Canada) and anti-
mouse F4/80 (1:50; Serotec, Oxford, U.K.). Antibody bind-
ing was detected with the avidin:biotinylated enzyme com-
plex (Vectastain ABC kit; Vector Laboratories, Inc.,
Burlingame, CA). Peroxidase activity was revealed using
3.3-diaminobenzidine (Sigma) as a substrate. Two types of
controls were performed: the primary antibody was omitted
during the immunostaining procedure, and the primary an-
tibody was substituted with non-specific Ig G during the
procedure. Sections were counterstained with hematoxylin.
Morphometry
Sections were visualized with a Zeiss microscope (Ax-
ioskop 40; Carl Zeiss GmbH, Jena, Germany) using a Plan-
Neofluor 10 objective and photographed with a Kodak
digital camera (DC290 Zoom; Eastman Kodak, Rochester,
NY). Quantitative analyses of immunopositive cells were
made using MetaMorph software (Molecular Devices
Corp., Sunnyvale, CA). For macrophage quantitation, adi-
pocytes and macrophages were counted from five fields,
and the results are presented as the mean of the five fields.
Statistics
Data presented are mean  standard error. Statistical
analyses were performed using JMP IN 5.1 statistical soft-
ware (SAS Institute, Inc., Cary, NC). Differences between
genotypes were assessed by ANOVA within dietary treat-
ment groups for normally distributed data and Tukey-
Kramer honestly significant difference post hoc test. Sig-
nificance was assumed for p values 0.05.
Results
Body Composition and Serum Analysis
Fasting insulin, adiponectin, and inflammation of adipose
tissue were examined in 6-month-old mice fed LFD or
exposed to HFD for 1 or 3 months. The LFD and 3-month
HFD body weight and adiposity data have been published
previously (14). Adiposity data of female WT, Mc3rKO,
and Mc4rKO from that report are incorporated as part of the
data set for Figure 1D. After 3 months on HFD, there was
no difference in adiposity between Mc3rKO and Mc4rKO
[WT, 38.2  1.6%; Mc3rKO, 54.0  2.2%; Mc4rKO,
50.1  2.2%; p  0.05; WT  Mc3rKO, Mc4rKO (14)].
Mc3rKO and Mc4rKO were moderately hyperglycemic
compared with WT on LFD (Figure 1A). Mc4rKO fed HFD
for 1 month exhibited the most severe hyperglycemia (fast-
ing glucose 200 mg/dL), which was not observed after 3
months of exposure to HFD (Figure 1A), possibly due to a
compensatory increase in the production of insulin by
-cells (Figure 1B). Mc4rKO displayed hyperinsulinemia
compared with WT irrespective of diet, whereas Mc3rKO
did not exhibit significantly higher fasting insulin levels
compared with WT (Figure 1B). Serum leptin levels were
increased in Mc4rKO on LFD and after 1 month of expo-
Figure 1: Fasting glucose (A), insulin (B), and serum leptin (C) in
WT, Mc3rKO, and Mc4rKO maintained on LFD or HFD for either
1 or 3 months. (D) Relationship between serum leptin and adipos-
ity (percentage body fat) in WT, Mc3rKO, and Mc4rKO. * p 
0.05 compared with WT. † p  0.05 compared with Mc3rKO.
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sure to HFD compared with WT and Mc3rKO, with 3
months of HFD elevating serum leptin in Mc3rKO to sim-
ilar levels as Mc4rKO (Figure 1C). Overall, serum leptin
correlated significantly with adiposity when all mice were
grouped (r2  0.86, p  0.001, Figure 1D).
Hypoadiponectemia Associated with Obesity in Mc4rKO
But Not in Mc3rKO
Expression of adiponectin mRNA (Acrp30) in retroperi-
toneal white adipose tissue (WAT) of WT, Mc3rKO, and
Mc4rKO was affected by exposure to HFD, decreasing with
long-term exposure to HFD irrespective of genotype (Figure
2A). Acrp30 mRNA was significantly lower in Mc4rKO
compared with WT and Mc3rKO, irrespective of diet (Fig-
ure 2A). Long-term exposure to HFD reduced Acrp30
mRNA in Mc3rKO compared with WT mice. Two-way
ANOVA revealed significant effect of diet and genotype on
Acrp30 gene expression (p  0.001). Serum adiponectin
levels generally correlated with Acrp30 mRNA. However,
although Acrp30 mRNA was significantly reduced in
Mc3rKO compared with WT after 3 months on HFD, there
was no significant difference in serum adiponectin (Figure
2B). Moreover, although Acrp30 mRNA was significantly
lower in Mc4rKO related to WT and Mc3rKO on LFD
(Figure 2A), this was not associated with a statistically
significant reduction in serum adiponectin (Figure 2B).
Several different molecular weight (MW) species of adi-
ponectin are observed in serum, correlating with the forma-
tion of trimers, hexamers, and multimeric complexes, with
HMW forms having more important effects on insulin sen-
sitivity status (27). The MW forms of adiponectin were
analyzed using non-denaturing polyacrylamide gel electro-
phoresis and Western blot. Mc4rKO demonstrated reduced
levels of the higher molecular weight isoforms of adiponec-
tin, whereas Mc3rKO exhibited normal levels of the MMW
and HMW forms of adiponectin (Figure 2C).
Increase in Expression of Macrophage-Specific Genes
in Mc4rKO and by HFD
Macrophages in adipose tissue were analyzed using the
expression of two macrophage-specific genes: Cd68, a mac-
rophage-specific transmembrane protein; and Emr1, the
F4/80 antigen. On LFD, Mc4rKO exhibited a modest but
statistically significant increase in the expression of Cd68
and Emr1 compared with WT and to Mc3rKO for Emr1
(Figure 3, A and B). Short-term exposure to HFD greatly
increased expression of both genes to a far greater extent in
Mc4rKO than in Mc3rKO; however, after 3 months of
exposure to HFD, we observed significantly elevated levels
of Cd68 and Emr1 mRNA in Mc3rKO (Figure 3, A and B).
Similar results were also observed for expression of Mcp1,
which was elevated in Mc4rKO on LFD compared with WT
and was greatly increased by HFD (Figure 3C). After 3
months of exposure to HFD, Mcp1 expression in Mc4rKO
was reduced compared with Mc3rKO but remained greater
than WT (Figure 3C).
Emr1 and Cd68 gene expression data were confirmed by
visualizing macrophages present in retroperitoneal WAT of
WT, Mc3rKO, and Mc4rKO using an antibody targeted to
the macrophage-specific antigen Mac-2 (Figure 4A). Over-
all, the ratio of macrophages per number of adipocytes
visualized using immunohistochemistry supported the Cd68
and Emr1 gene expression data and was highest in Mc4rKO,
irrespective of diet (Figure 4, B to D). Mc4rKO exhibited
pronounced inflammation of adipose tissue, which was ex-
acerbated by HFD, whereas Mc3rKO demonstrated an at-
tenuated and delayed inflammatory response to HFD.
The interaction among fat mass, inflammation, and hy-
perinsulinemia is further illustrated in Figure 5. Expression
Figure 2: Serum adiponectin and adiponectin gene expression are
reduced in Mc4rKO. (A) Adiponectin gene expression in retroper-
itoneal WAT from WT, Mc3rKO, and Mc4rKO maintained on
LFD or HFD for either 1 or 3 months. (B) Relationship between
serum adiponectin and adiposity separated by dietary treatment.
(C) The differences in patterns of adiponectin oligomeric complex
distribution in WT, Mc3rKO, and Mc4rKO on LFD or HFD for 3
months. Mouse serum samples (1 L) from mice were separated
by gel electrophoresis, transferred to nitrocellulose, and subjected
to Western blot analysis. * p  0.05 compared with WT. † p 
0.05 compared with Mc3rKO.
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of Cd68 mRNA remains low in adipose tissue of all mice
below a threshold level of adiposity (45%), and when
adiposity exceeds this threshold, Cd68 expression is greatly
increased (Figure 5A). Similar relationships were also ob-
served between adiposity and Emr1 and Mcp1 expression
(data not shown). The association between hyperinsulin-
emia and Cd68 expression with adiposity is similar (Figure
5B). When a particular level of adiposity is achieved, evi-
dence of macrophage infiltration and hyperinsulinemia be-
comes apparent.
Fat Cell Size Correlation with Obesity in Obese
Melanocortin Receptor-Deficient Mice
Exposure to HFD for 1 or 3 months was associated with
adipocyte hypertrophy in WT without significantly altering
total adipocyte number (Table 1). On LFD, Mc3rKO and
Mc4rKO exhibited adipocyte hypertrophy, although total
fat cell number was not significantly different (Table 1).
Exposure to HFD for 1 month induced marked adipocyte
hypertrophy and hyperplasia in Mc4rKO, while increasing
adipocytes size in Mc3rKO. Three months on HFD resulted
in both Mc3rKO and Mc4rKO exhibiting adipocyte hyper-
plasia, compared with WT (Table 1). Fat cell size correlated
strongly with adiposity when all mice were combined (r2 
0.83, p  0.001; data not shown), but was not strongly
associated with Cd68 mRNA (not shown). Although
smaller adipocytes size was associated with a low inflam-
matory state, adipocyte hypertrophy was not a prerequisite
for macrophage infiltration in Mc4rKO (data not shown).
Discussion
The hypothalamic melanocortin system regulates insulin
secretion and sensitivity independently of effects on body
weight (11,13). Central administration of non-selective
melanocortin receptor antagonists is associated with insulin
resistance (11). The analysis of diabesity in Mc3rKO and
Mc4rKO involving mice on outbred backgrounds (129;B6)
suggested that loss of Mc4r has a more significant impact on
both obesity and insulin resistance (12,22,28). These results
were supported by our analysis of insulin sensitivity in age-
and weight-matched Mc3rKO and Mc4rKO backcrossed
onto C57BL/6J (14), a strain frequently used to investigate
obesity and insulin resistance (for review, see 29). The
objective of the current study was to further investigate
mechanisms explaining the differential effects of diet and
obesity on insulin resistance in Mc3rKO and Mc4rKO.
Overall, the current data are consistent with previously
published data demonstrating the relative importance of
Mc3r and Mc4r in maintaining body weight and insulin
sensitivity (14). The novel data reported herein suggest that
differences in the effect of obesity on serum adiponectin,
and to a lesser degree the inflammatory state, may at least
partially explain the mild insulin-resistant phenotype of
Mc3rKO compared with Mc4rKO.
Hotamisligil et al. (30) suggested that tumor necrosis
factor  produced by adipocytes and macrophages contrib-
utes to the development of insulin resistance in the obese
state, prompting the hypothesis that insulin resistance may
be prevented or attenuated by inhibition of inflammation.
The relationship between macrophage infiltration of adipose
tissue and the development of insulin resistance has been
further investigated in recent years (for review, see 4). The
list of secreted factors produced by adipocytes contributing
to inflammation and insulin resistance has expanded to
include interleukin-6, resistin, MCP-1, leptin, and adiponec-
tin, among several others. The role of inflammatory factors
in the progression of obesity and metabolic syndrome in
Mc4rKO and Mc3rKO had not been explored. In the current
Figure 3: Expression of macrophage-specific genes is associated
with adiposity. Retroperitoneal white adipose tissue expression of
the macrophage markers Cd68 (A), Emr1 (B), and the chemokine
Mcp1 (C) in WT, Mc3rKO, and Mc4rKO exposed to LFD or HFD
for either 1 or 3 months. * p  0.05 compared with WT. † p 
0.05 compared with Mc3rKO.
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study, macrophage infiltration in WAT tended to be higher
in Mc4rKO compared with WT and Mc3rKO on LFD and
was dramatically increased in Mc3rKO and Mc4rKO on
exposure to HFD for 3 months. Mc3rKO, however, exhib-
ited a delayed response to HFD such that, even after 3
months of maintenance on HFD, Mac-2-positive staining in
WAT was not equivalent to that of Mc4rKO.
Obese leptin-deficient Lepob/Lepob mice exhibit high lev-
els of Cd68 gene expression and macrophage numbers in
WAT (18), whereas Xu et al. (19) also reported an increased
expression of Cd68, Emr1, and Mcp1 genes in adipose
tissue of Lepdb/Lepdb. Adipose tissue Cd68 gene expression
is negatively associated with insulin sensitivity status in
humans, and increasing insulin sensitivity by pioglitazone
treatment is associated with a reduction in Cd68 mRNA in
adipose tissue (31). Reducing adipose tissue macrophage
content through targeted deletion or inhibition of MCP1 or
its receptor, C-C motif chemokine receptor-2, is associated
with improved insulin sensitivity (20,32). Macrophage in-
filtration and inflammation are, therefore, factors associat-
ing obesity with insulin resistance. The attenuated inflam-
matory profile of Mc3rKO could be a factor contributing to
mild insulin resistance observed in this model. Macro-
phages and a number of other cell types involved in the
immune function and inflammation express Mc1r and
Mc3r, with agonism of these receptors having an anti-
inflammatory effect (33). However, although activation of
Mc3r is anti-inflammatory, our data show inflammation
associated with obesity is actually delayed in Mc3rKO.
Whether Mc3r expressed on macrophages has a significant
role in the inflammatory response to diet-induced obesity
and whether loss of Mc3r protects against obesity-related
inflammation was not determined in these studies. On the
Figure 4: Macrophage infiltration and adipocyte hypertrophy are evident in Mc4rKO and are increased by HFD. (A) Representative images
of retroperitoneal WAT sections stained for Mac-2, a macrophage-specific antigen, from WT, Mc3rKO, and Mc4rKO maintained on LFD
or HFD for either 1 or 3 months. The total number of adipocytes (B) and Mac-2-positive cells (C) were counted from five random fields.
The ratio of the number of macrophages relative to the total number of adipocytes (D) shows macrophage infiltration occurring in Mc3rKO
and Mc4rKO after exposure to HFD, with a smaller increase in WT. * p  0.05 compared with WT. † p  0.05 compared with Mc3rKO.
Figure 5: Relationship between the macrophage marker Cd68
mRNA and adiposity (A) and Cd68 mRNA and fasting insulin (B)
in WT, Mc3rKO, and Mc4rKO.
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other hand, Mc4rKO represents a new animal model of
obesity where severe insulin resistance is coupled with
inflammation.
The biology of adiponectin and its involvement in glu-
cose homeostasis is complex and under active investigation.
Adiponectin treatment attenuates alcohol- and obesity-re-
lated hepatomegaly and steatosis (34), whereas adiponectin
KOs can exhibit insulin resistance that is exacerbated by
diet (35). Serum adiponectin levels are regulated at the level
of synthesis and secretion (36) and the rate of clearance
from serum (25,37). The HMW isoforms of adiponectin are
more relevant to insulin sensitivity status than total levels of
adiponectin alone (38). We measured total serum adiponec-
tin levels and, using Western blot, investigated the MMW
and HMW isoforms. These results suggest differential ef-
fects of the obesity syndrome in Mc3rKO and Mc4rKO on
serum adiponectin as factors contributing to differences in
the insulin resistant phenotype. Mc3rKO and Mc4rKO on
HFD exhibit weight gain and reduced WAT Acrp30 mRNA
expression; however, serum adiponectin levels in Mc3rKO
remain comparable with WT. This may suggest differences
in adiponectin clearance in obese Mc4rKO and Mc3rKO.
Normal adiponectin levels could be a significant factor
contributing to the mild insulin-resistant phenotype and
mild hepatic steatosis observed in obese Mc3rKO fed HFD
(14). Conversely, the reduction in adiponectin in Mc4rKO,
observed for all MW forms, may contribute to the more
severe insulin-resistant phenotype of Mc4rKO. However,
insulin and glucose infusions have both been shown to
reduce the HMW forms of adiponectin in mice (37). The
more marked deterioration of glucose homeostasis associ-
ated with HFD may, therefore, also further aggravate hy-
poadiponectinemia in Mc4rKO.
Interventions that reduce reactive oxygen species reverse
hypoadiponectinemia and improve diabetes, hyperlipid-
emia, and hepatic steatosis in obese mice (36). The Acrp30
mRNA expression data, demonstrating a delayed decline in
expression in Mc3rKO relative to Mc4rKO, may suggest
differences in the effects of diet and genotype on oxidative
stress in adipose tissue. A previous study reported an in-
crease in adiponectin gene expression in mice after short-
term exposure to HFD (39). However, in this study, a
1-month exposure to HFD did not result in significant
changes in Acrp30 mRNA in WT or Mc3rKO.
The relationship between the obesity phenotype of
Mc4rKO and Mc3rKO and fat cell size is diet-dependent.
On LFD, obesity in Mc4rKO and, to a lesser degree,
Mc3rKO is distinguished by adipocyte hypertrophy, with no
significant difference in the estimates of adipocyte number.
Weight gain in Mc4rKO fed HFD diet is associated with
adipocyte proliferation causing a rapid increase in the num-
ber of adipocytes, appearing to plateau within 1 month of
exposure. In contrast, adipocyte hyperplasia in Mc3rKO is
only observed with prolonged exposure to HFD. A capacity
for triglyceride deposition into adipocytes and adipocyte
proliferation have been suggested to protect against type 2
diabetes, allowing for partitioning of lipid to adipose and
preventing lipotoxic effects in insulin target tissues and
-cells (40). Moreover, excess deposition of lipid metabo-
lites in liver and muscle in situations of impaired adipocytes









LFD WT 0.23  0.05 8.8  1.3 29.2  5.3
Mc3rKO 0.51  0.05* 3.9  1.4 22.1  5.3
Mc4rKO 0.78  0.06*† 1.9  1.6* 34.3  5.8
HFD, 1 month WT 0.71  0.05 2.3  0.1 20.5  2.5
Mc3rKO 0.93  0.05* 1.6  0.1 26.1  2.9
Mc4rKO 1.10  0.06* 2.2  0.2 64.1  3.2*†
HFD, 3 months WT 0.95  0.04 1.8  0.1 24.6  2.7
Mc3rKO 1.19  0.06* 2.0  0.1 52.3  3.8*
Mc4rKO 0.85  0.06† 2.2  0.1 64.3  3.8*
WT, wild type mice; KO, knockout; Mc3rKo, Mc3r KO mice; Mc4rKo, Mc4r KO mice; LFD, low-fat diet; HFD, high-fat diet. Total
adipocyte number was calculated by multiplying the number of adipocytes per milligram of tissue by the amount of triglyceride (fat mass
in grams) per animal measured by nuclear magnetic resonance.
* p  0.05 compared with WT mice.
† p  0.05 compared with Mc3rKO mice.
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proliferation is associated with insulin resistance (41). It
seems reasonable, therefore, to speculate that a continued
capacity for adipocyte proliferation and an expansion in
adipocytes size may contribute to the mild insulin resistant
phenotype of Mc3rKO.
For Mc4rKO, the effect of genotype and diet on insulin
resistance is complex and tissue specific. Hepatic insulin
resistance and hepatic steatosis develop in mildly obese
Mc4rKO fed LFD, occurring independently of dietary fat
content and presumably adipocyte hypertrophy (14,23).
Mc4r, thus, appears to have a critical role in the normal
regulation of liver metabolism and prevention of fatty liver
disease in the mildly obese state. The relative contribution
of hyperphagia and impaired autonomic or neuroendocrine
inputs, such as leptin resistance and hypoadiponectinemia,
to the fatty liver phenotype of Mc4rKO requires further
investigation. Moreover, whether Mc4r signaling in
Mc3rKO also functions to protect against severe fatty liver
disease in the obese state is not clear.
In summary, we present data to show that in situations of
adipocyte hypertrophy and hyperplasia associated with diet-
induced obesity, Mc4rKO exhibit a severe inflammatory
response in adipose tissue coupled with marked hyperinsu-
linemia and reduced serum adiponectin. The mild state of
insulin resistance in severely obese Mc3rKO on HFD may
be partially explained by the retention of relatively normal
levels of adiponectin, combined with a delayed inflamma-
tory response.
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